Cart
sales@molnova.com
debutylbupivacaine
CAS No. 15883-20-2
debutylbupivacaine( Desbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine )
Catalog No. M12267 CAS No. 15883-20-2
It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 57 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 174 | In Stock |
|
| 200MG | 312 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namedebutylbupivacaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
In Vitro——
-
In Vivo——
-
SynonymsDesbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15883-20-2
-
Formula Weight232.32
-
Molecular FormulaC14H20N2O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(C1NCCCC1)NC2=C(C)C=CC=C2C
-
Chemical Name2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pihlajam?ki K, et al. Br J Anaesth. 1990 May;64(5):556-62.
molnova catalog
related products
-
MSNBA
MSNBA is a selective and potent inhibitor of fructose transport through GLUT5 and also acts as a probe of the GLUT5 transporter. MSNBA inhibited GLUT5 fructose uptake in MCF7 cells with KI of 3.2±0.4 μM.
-
2-Iminothiolane HCl
2-Iminothiolane HCl is a useful RNA-protein crosslinking reagent and an effective thiolation reagent for the introduction of sulphydryl groups into oligosaccharides.
-
diaminohydroxypropan...
Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others
